Emcure Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
You can view the
Halfyearly Results
for the last 5 years.
Market Cap. (Rs.)
|
25648.06 Cr.
|
P/BV
|
6.23
|
Book Value (Rs.)
|
217.34
|
52 Week High/Low (Rs.)
|
1580/889
|
FV/ML
|
10/1
|
P/E(X)
|
37.64
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
35.95
|
Div Yield (%)
|
0.22
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 4078.88 | 3817.12 | 3219.25 |
Total Income From Operations | 4078.88 | 3817.12 | 3219.25 |
| | | |
EXPENDITURE | | | |
Consumption of Raw Materials | 803.70 | 723.20 | 659.22 |
Purchase of Traded Goods | 1000.79 | 882.45 | 520.59 |
Increase/Decrease in Stocks | -129.65 | -133.88 | 2.88 |
Employees Cost | 740.30 | 705.99 | 621.49 |
Depreciation | 193.64 | 190.49 | 122.35 |
Other Expenses | 906.73 | 922.17 | 790.42 |
Total Expenses | 3515.51 | 3290.42 | 2716.95 |
| | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 563.36 | 526.70 | 502.31 |
Other Income | 8.35 | 59.10 | 16.31 |
P/L Before Interest, Excpt. Items & Tax | 571.71 | 585.80 | 518.62 |
Interest | 70.80 | 104.98 | 126.12 |
P/L Before Exceptional Items & Tax | 500.91 | 480.82 | 392.50 |
Exceptional Items | -10.38 | 0.00 | -3.13 |
P/L Before Tax | 490.53 | 480.82 | 389.37 |
Tax | 137.20 | 126.68 | 102.57 |
P/L After Tax from Ordinary Activities | 353.33 | 354.14 | 286.80 |
Net Profit/Loss For the Period | 353.33 | 354.14 | 286.80 |
Minority Interest | -10.65 | -15.49 | -17.24 |
Net P/L After Minority Interest & Share Of Associates | 342.68 | 338.65 | 269.56 |
| | | |
Equity Share Capital | 189.48 | 189.10 | 180.85 |
EPS Before Extra Ordinary * | | | |
Basic EPS (Rs.) | 18.65 | 18.33 | 15.86 |
Diluted EPS (Rs.) | 18.65 | 18.33 | 15.86 |
EPS After Extra Ordinary * | | | |
Basic EPS (Rs.) | 18.65 | 18.33 | 15.86 |
Diluted EPS (Rs.) | 18.09 | 18.33 | 14.91 |
| | | |
PBITOE Margin (%) | 13.81 | 13.79 | 15.60 |
PBTE Margin (%) | 12.28 | 12.59 | 12.19 |
PBT Margin (%) | 12.02 | 12.59 | 12.09 |
PAT Margin (%) | 8.66 | 9.27 | 8.90 |
PAT After MI And SOA Margin (%) | 8.40 | 8.87 | 8.37 |